We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Gold Supplier
Procalcitonin Test
Alpha-1 Antitrypsin Deficiency Test
A1AT Genotyping Test
H. pylori Test
H. pylori Antigen Rapid Test Kit
Semi-Auto Rotary Microtome
Visit expo >

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Molecular Diagnostics

Image: Researchers have identified the origin of subset of autoantibodies that worsen lupus (Photo courtesy of Pexels)

Lupus Biomarker Testing Could Help Identify Patients That Need Early and Aggressive Treatment

Scientists researching the origins of systemic lupus erythematosus and the reasons why some patients have more severe symptoms than others have discovered a type of autoantibody that could worsen the disease and identified how these autoantibodies are formed. More...
31 Mar 2023
Image: New research by neuroscientists will lay the groundwork for Alzheimer’s disease precision medicine (Photo courtesy of Pexels)

Blood Test for Multiple Pathways Related to Alzheimer’s Could Enable Earlier and Less-Invasive Diagnosis

A five-year, USD 41 million study, titled Centrally-linked Longitudinal Peripheral Biomarkers of AD, or CLEAR-AD, that involves over 40 experts and 13 institutions across the U.S. and abroad, will facilitate collaboration and promote progress in Alzheimer's disease research through several innovative approaches. More...
31 Mar 2023
Image: The Gazelle Hb Variant test identifies hemoglobin disorders rapidly, easily, and inexpensively (Photo courtesy of Hemex Health)

POC Test Detects Genetic Blood Disorders with High Accuracy

Sickle cell disease (SCD) and beta thalassemia are genetic blood disorders that affect over 7% of the global population. In the US, SCD is estimated to affect 100,000 people, with up to 8% of African-Americans being carriers, and can reduce life expectancy by up to 20 years. Now, an affordable sickle cell and beta thalassemia test that is currently used in 27 countries seeks to replicate its international success and expand into the U.S. More...
31 Mar 2023
Image: COLOTECT 1.0 can help improve colorectal cancer prevention and early detection (Photo courtesy of BGI)

Non-Invasive Fecal DNA Test Accurately Detects Colorectal Cancer and Precancerous Lesions

BGI Genomics has developed a non-invasive fecal DNA test, known as COLOTECTTM 1.0, to detect colorectal cancer and precancerous lesions. The test employs multiplex methylation-specific PCR (MSP) technology to track abnormal DNA-methylation biomarkers in stool samples. More...
30 Mar 2023
Image: RNA biomarkers may one day help diagnose heart disease (Photo courtesy of Pexels)

Simple Blood Test Could Help Doctors Diagnose Heart Disease in Physician's Office

In the largest analysis of blood RNA from patients with angiographically confirmed coronary artery disease (CAD), researchers have demonstrated how RNA biomarkers could be utilized to confirm heart disease. More...
30 Mar 2023
Image: Testing for a serum protein could speed identification of patients who need liver transplants (Photo courtesy of Pexels)

Serum Protein Test Can Predict Outcomes for Liver Failure Patients

A new study has revealed that levels of a serum protein called carbamoyl phosphate synthetase 1 (CPS1), which is short-lived but abundant, can accurately predict outcomes for patients with acute liver failure - whether they will recover or require a transplant. More...
29 Mar 2023
Image: Fujirebio has launched the fully automated Lumipulse G NfL CSF and Lumipulse G NfL blood tests (Photo courtesy of Fujirebio)

Fully Automated Blood-Based Assays Measure Biomarker for Neurodegenerative Diseases within 35 Minutes

Fujirebio has launched the fully automated Lumipulse G NfL CSF and Lumipulse G NfL Blood CLEIA (chemiluminescent enzyme immunoassay) assays for the LUMIPULSE G immunoassay systems that enable the quantitative measurement of neurofilament light (NfL) in human Cerebrospinal fluid (CSF) and plasma/serum, respectively, in only 35 minutes. More...
29 Mar 2023

Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2023 Globetech Media. All rights reserved.